1. A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia. (17th April 2013) Authors: Kennedy, Glen A.; Morris, Kirk L.; Subramonpillai, Elango; Curley, Cameron; Butler, Jason; Durrant, Simon Journal: British journal of haematology Issue: Volume 161:Number 6(2013:Jun.) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗